NCT02739672View on ClinicalTrials.gov

Clinical Trial to Compare the Pharmacokinetics of TAH Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 2, 2016

Primary Completion Date

April 6, 2016

Study Completion Date

April 6, 2016

Conditions
Healthy
Interventions
DRUG

TAH Tablet (Telmisartan/Amlodipine besylate/Hydrochlorothiazide)

Telmisartan 80.0 mg, Amlodipine besylate 13.87 mg (Amlodipine 10 mg), Hydrochlorothiazide 25 mg combination-drug would be administered orally once

DRUG

TWYNSTA(Telmisartan+Amlodipine besylate)

TWYNSTA 2 Tab. 40/5mg(Telmisartan 40 mg, Amlodipine besylate 6.935 mg(Amlodipine 5 mg) would be administered orally once

DRUG

Hydrochlorothiazide

Dichlozid 1 Tab.(Hydrochlorothiazide 25.0 mg) would be administered orally once

Trial Locations (1)

561-712

Chonbuk National University Hospital, Chonbuk

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT02739672 - Clinical Trial to Compare the Pharmacokinetics of TAH Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter